This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Accuray's Medical Systems to be Acquired by Dubai Hospital
by Zacks Equity Research
Accuray Inc. (ARAY) recently announced that it has signed an agreement with the Neuro Spinal Hospital in Dubai, United Arab Emirates.
DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay
by Zacks Equity Research
On Jul 12, we issued an updated research report on NY-based DENTSPLY SIRONA Inc. (XRAY) -- a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.
McKesson (MCK) Poised on Improving Generic and Brand Market
by Zacks Equity Research
On Jul 12, we issued an updated research report on San Francisco, CA-based McKesson Corporation (MCK).
Masimo (MASI) Rainbow Super DCI-mini Sensor Now CE Marked
by Zacks Equity Research
Irvine, CA-based Masimo Corporation (MASI) recently announced the receipt of CE mark for the noninvasive and reusable rainbow Super DCI-mini sensor.
Fresenius Medical (FMS) Well Poised on Growth Strategy 2020
by Zacks Equity Research
On Jul 11, we issued an updated research report on Bad Homburg, Germany-based Fresenius Medical Care (FMS), one of the largest integrated providers of products and services for individuals undergoing dialysis following chronic kidney failure.
Becton, Dickinson (BDX) Poised on C.R. Bard Acquisition
by Zacks Equity Research
On Jul 7, we issued an updated research report on Franklin Lakes, NJ-based Becton, Dickinson and Company (BDX).
Mazor Expects Higher Q2 Revenues, Wins Mazor X Orders
by Zacks Equity Research
Mazor Robotics Ltd. (MZOR), recently announced that it expects to report second-quarter 2017 revenue of approximately $15.4 million compared with $8.3 million from the year-ago quarter.
Envision Healthcare Rallies on Infinity Healthcare Buyout
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) recently announced that Envision Physician Services has acquired Infinity Healthcare, a multi-specialty physician group practice.
Exactech (EXAC) Launches Application for Knee Replacement
by Zacks Equity Research
Gainesville, FL-based Exactech Inc. (EXAC) recently announced the launch of a new software application christened ExactechGPS TKA PLUS.
Civitas Solutions (CIVI) Acquires Country Life Care Center
by Zacks Equity Research
Civitas Solutions, Inc. (CIVI) recently announced the acquisition of Country Life Care Center, a rehabilitation and post-acute care facility located in Riverton, UT.
Patterson Companies Grapples with Multiple Issues: Dump Now?
by Zacks Equity Research
On Jul 4, we issued an updated research report on St. Paul, MN-based The Patterson Companies (PDCO).
Veeva (VEEV) Set to Grow on Subscription Revenue Focus
by Zacks Equity Research
On Jul 4, we issued an updated research report on Pleasanton, CA-based Veeva Systems Inc. (VEEV).
PerkinElmer (PKI) Hits a 52-Week High on Multiple Positives
by Zacks Equity Research
PerkinElmer Inc. (PKI) rallied to a new 52-week high of $69.19 on Jul 3, closing lower at $67.73.
Here's Why You Should Dump Quality Systems (QSII) Stock Now
by Zacks Equity Research
On Jul 4, we issued an updated research report on Irvine, CA-based Quality Systems Inc (QSII) -- a developer and marketer of healthcare information systems.
Varian Halcyon System Gets 510(k) Approval from the FDA
by Zacks Equity Research
Palo Alto, CA-based manufacturer of medical devices and software, Varian Medical Systems, Inc. (VAR) recently announced the 510(k) approval for its Halcyon system.
Luminex Gets CE Mark for ARIES Norovirus Assay, Shares Rally
by Zacks Equity Research
Shares of Luminex Corporation (LMNX) gained 1.5% to close at $21.38 after the company announced the receipt of CE-IVD mark for the ARIES Norovirus Assay.
Ensign Group (ENSG) Acquires Facilities in Texas & Wisconsin
by Zacks Equity Research
The Ensign Group, Inc. (ENSG) recently announced that it acquired the real estate and operations of two assisted living facilities in Texas and three assisted living facilities in Wisconsin.
Edap Tms (EDAP) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Edap Tms SA (EDAP)
Why Investors Should Retain Molina Healthcare (MOH) Stock
by Zacks Equity Research
Molina Healthcare, Inc. (MOH) consistent operating performance is backed by its steady increase in premiums and service revenues, effective inorganic growth initiatives and solid fundamentals.
Teladoc (TDOC) to Raise Debt for Best Doctors Acquisition
by Zacks Equity Research
Teladoc, Inc. (TDOC) announced recently that it would offer senior notes worth $200 million, with the year of maturity fixed as 2022.
Teladoc (TDOC) to Buy Best Doctors, Stock Hits New High
by Zacks Equity Research
Teladoc Inc. (TDOC) has inked a definitive agreement to acquire Best Doctors, a leader in medical consultation.
Universal Health Grows on Acquisitions, Rising Debt a Drag
by Zacks Equity Research
Universal Health Services, Inc.'s (UHS)s inorganic strategies substantially make it well positioned for long-term growth.
Looking for a Top Momentum Stock? 3 Reasons Why EDAP TMS (EDAP) is a Great Choice
by Zacks Equity Research
EDAP TMS (EDAP) is a solid momentum stock that has a favorable Zacks Rank and is seeing solid earnings estimate revisions.
Can EDAP TMS (EDAP) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
EDAP TMS (EDAP) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.
EDAP TMS (EDAP) Shows Strength: Stock Adds 5.9% in Session
by Zacks Equity Research
EDAP TMS S.A. (EDAP) moved big last session, as its shares jumped almost 6% on the day.